SUNPHARMA - Sun Pharmaceutical Industries

Sun Pharmaceutical Industries

SUNPHARMA · Pharma > Pharmaceuticals & Drugs · Chairman: Israel Makov · MD: Dilip S Shanghvi · Listing date: Feb. 8, 1995 · Employees: 37000 · Mumbai · http://www.sunpharma.com

Stock Price vs Company Growth

0.5%

0.6%

4.2%

5.8%

3.5%

7.1%

25.0%

10y

8.7%

all

17.1%

🤔 How to analyze this graph?

Last Traded Price

₹ 1,729 0.5%

1,620

1,844

Company Overview

Sales

54,964 Cr

Growth: 8.8%

Profit after Tax

10,450 Cr

Growth: 0.7%

Large Cap

4,14,929 Cr

P/E: 39.7x

Industry P/E: 32.9x

Fundamentals

Sales (Cr)	₹ 54,964
Growth	8.8%
EBITDA	28.4%
P/S	7.5x
Dividend	0.9%
P/E	39.7x
Book Value	₹ 323
PEG Ratio	4.5x
ROE	14.1%
P/B	5.3x

Shareholding Pattern

Institutions

Life Insurance Corporation Of India

7.37 %

Icici Prudential Value Discovery Fund And Various Fund Accounts

3.68 %

Sbi-Etf Nifty 50 And Various Fund Accounts

1.94 %

Hdfc Trustee Company Limited-Hdfc Balanced Advantage Fund And Various Fund Accounts

1.37 %

Nippon Life India Trustee Ltd-A/C Nippon India Pharma Fund And Various Fund Accounts

1.24 %

Promoters

Shanghvi Finance Private Limited

40.3 %

Dilip.S.Shanghvi

9.6 %

Aditya Medisales Limited

1.67 %

Raksha S.Valia

1.2 %

Sudhir V.Valia

0.6 %

Others

Llp

2.89 %

Lakshdeep Investments & Finance (P) Ltd.

1.18 %

Iepf

0.08 %

Increase Decrease No change

Company Profile Detailed

The company is among the largest specialty generic pharmaceutical company and India's top pharmaceutical company. A vertically integrated business and a skilled team enables it to deliver high-quality products, trusted by customers and patients in many countries across the world, at affordable prices.ProductsFormulationsActive Pharmaceutical Ingredients - CramsOTCAwards 2005: Dilip Shanghvi is named Entrepreneur of the Year (Healthcare and Life Science) Ernst & Young.

Belongs to (55 Indices) view more

Investors (337)

subson

shanghvi...

varsha.k...

Followers (136)

bharath....

kiran198...

anil